Diteba is a cGMP/GLP pharmaceutical laboratory located near Toronto, Canada that offers analytical R&D services including method development and validation, bioanalytical testing, quality control release testing, stability testing, and in vitro release testing. The company has over 10,000 square feet of laboratory space equipped with state-of-the-art instrumentation. Diteba's team of senior scientists have extensive experience across various therapeutic areas and analytical techniques.

1. Corporate Capabilities Presentation www.diteba.com

2. Who We Are Founded in 2003 operating since October 2005 cGMP/GLP laboratory located minutes from Toronto Airport State-of-the-art 10,000 sq. ft. facility Licensed by Health Canada as a GMP drug establishment for Controlled Substances, Drugs and Precursors Registered with U.S. FDA Expertise in both small and large molecules

3. What We Offer Analytical R&D Services Bioanalytical Services QC Release Testing Stability Testing Physical Testing Analytical Support for Formulation Development Cleaning Validation and Verification Testing In Vitro Release Rate Testing Services

4. What We Offer We are committed to the success of our clients through the acceleration of their R&D intensive projects Diteba is uniquely positioned to deliver the R&D services and acumen our clients demand with our Team of industry experts World-class pharmaceutical laboratory Comprehensive laboratory informatics infrastructure Extensive academic network We strive to be an innovative and cost effective partner that delivers consistent and quality services with unmatched integrity

5. What We Offer Senior scientific staff offers impeccable credentials and experience in areas of: cGMP Analytical Testing GLP Bioanalytical Testing Biologics Testing In Vitro Release Rate Testing Custom designed and built laboratory with state-of-the-art instrumentation Operational design and efficiencies allow for flexibility and responsiveness Complete e-lab informatics infrastructure to electronically capture and store all data that is 21 CFR Part 11 compliant

6. What We Offer Senior scientists are involved directly with projects provides for: Demonstrated creative, proactive approaches to solve the most complex technical challenges Individualized approach with quicker turnaround times Highly Responsive Maintain available capacity for scheduling flexibility Friendly attitude Cost-effective solutions to reduce overall costs and improve processing times

7. Our Organization

8. Management and Key Personnel Dr. Theo Kapanadze, D.Sc., Ph.D., Chief Scientific Officer, Executive VP Science More than 30 years experience as an academic researcher, university professor and leading research scientist at major pharmaceutical and CRO companies Has worked extensively in areas such as: Pharmaceutical research and development BA/BE and drug interaction studies Led projects that provided analytical support for: Formulation development Toxicology & clinical programs Stability studies Over 16 semisolid In Vitro Release Testing projects (SUPAC-SS) Credited with over 40 publications

9. Dr. Steve Li, M.D., M.Sci. (Pharm), Manager of Laboratory Operations More than 20 years of research experience in the fields of: Biomedical research Clinical pharmacology Biotechnology Has worked extensively in: Method development and validation Stability support Cleaning validation Credited with over 35 publications and awards Management and Key Personnel

10. Management and Key Personnel Slavica Mogic, MSc., BSc., Manager of QA & RA Scientific strength is in the knowledge of biomacromolecules, including methodologies utilized for the analysis of proteins, enzymes and immunoglobulins Over 15 years of industry QA/RA experience gathered in Global bio/pharma companies and leading CRO’s in the areas of: Raw material testing Finished product release testing Stability testing Analytical method development and validation Has knowledge of regulatory guidelines such as: Health Canada U.S. FDA EMA ICH Guidelines

11. Regulatory History DATE REGULATORY AGENCY CATEGORY RATING/Status Sep 2005 Health Canada Pharmaceuticals C (Compliant) July 2006 Health Canada Control Drugs and Substances Status: licensed Feb 2008 Health Canada Biologicals; Pharmaceuticals C (Compliant) Feb 2009 Health Canada Class A Precursors Status: licensed Mar 2010 Health Canada Biologicals; Pharmaceuticals C (Compliant)

12. Analytical R&D Services Method development and validation for: Drug substances and intermediates Raw materials and excipient ingredients Drug products Stability-indicating methods Forced degradation studies Impurities & degradation Equally adept at small or large molecules

13. QC Release Testing Services Characterization or release testing of: Drug substances and intermediates Raw material compendial testing USP/NF, EP, JP Impurity, Metabolite and Degradation Product Identification Reference materials CTM supplies and comparator products In-process lots Commercial finished product release Controlled substances and precursors

14. Physical Testing Services Loss on Drying, ROI Moisture (Karl Fisher Titration & Coulometric) Color Determination Deliverable Volume Density & Specific Gravity Disintegration pH and Conductivity Product & Package Appearance Tablet Hardness & Friability Viscosity, Osmolarity, Particulates, TOC

15. Bioanalytical Testing Services Custom Assay method development and validation Pre-clinical animal and human clinical trials sample testing Healthy patient/volunteer samples Infectious populations samples Sample analysis technologies in multiple biological species and matrices for preclinical animal studies Bioanalysis of drug and metabolites in biological fluids Clinical trials support (TK, PK, BA/BE, Drug Interaction)

16. Bioanalytical Testing Services Expertise in many proven validated methods to measure all types of small or large molecule compounds using: UPLC/MS/MS HPLC - GFC UPLC – UV, FI, ECD Capillary and Gel Electrophoresis Gel Image analysis ELISA assays DNA hybridization Metabolite identification using LC/MS/MS Ultra-Low freezers with generator back-up for storage All work completed under GMP & GLP guidelines

17. Formulation Development Testing Vehicle compatibility testing Solubility testing Excipient compatibility studies Bench level formulation development contract services available Feasibility batch testing: Assay Content and blend uniformity testing

18. Stability Testing Services Drug substances and intermediates IND, NDA, ANDA Registration batches CTM batches and comparator products Commercial product Controlled substances and precursors Formulation evaluation stability testing Forced degradation studies Photo stability (UV and Daylight) per ICH Q1B Temperature cycling (freeze/thaw) Transportation studies Protocol design and report writing

19. Stability Storage Services Long-term and accelerated storage conditions per ICH Guidelines: 25 o C/60% RH 30 o C/65% RH 40 o C/75% RH 5 o C, -20 o C, -80 o C Special storage conditions available Stability chambers on automated generator back-up

20. Dissolution and In Vitro Release Testing Method development and validation Immediate and controlled release testing Testing per USP monograph articles Content uniformity testing Drug release testing

21. Semisolids In Vitro Release Testing In Vitro Release Testing (IVRT) of semisolids and transdermals using Franz Cell system Conforms to FDA Scale-up and Post Approval Changes for Semisolids Guidelines (SUPAC-SS) Conforms to USP Pharmacopeial Forum Vol. 35(3) May - June 2009 Product Quality and product performance tests for topical and transdermal products Defined product quality tests in General Chapter <3> Defined product performance tests <725>

22. Semisolids In Vitro Release Testing IVRT testing valuable for: In-process testing for formulation optimization QC on lot-to-lot variability Comparison testing for pre and post-change formulations Skin penetration studies Full method development and validation of IVRT and HPLC/UPLC assay methods Preparation of data interpretation and submission reports

23. State-of-the-art instrumentation including: HPLC UPLC, UPLC-MS/MS GC AA UV, FT-IR Dissolution systems Franz Cell and Enhancer Cell systems ELISA readers Capillary & Gel Electrophoresis SDS-Page EP TOC Stability chambers Physical testing equipment Key Equipment

24. State-of-the-Art Laboratory Infrastructure ’ . HPLC, UPLC, UPLC/MS GC EMPOWER Database ELN- TBD SDMS: NuGenesis Database UV, TOC, FTIR, AA, ELISA & Other applications without Database NuGenesis can also capture files from various applications that do not have their own database Final document for submission to client by Web access (in development) or in paper format. Balances & pH meter MS Office applications Temperature and Humidity Monitoring system for Stability Chambers by Rees Scientific

25. Key Partnership: Thesis Chemistry Analysis and separations Custom preparations Process chemistry development Chemical synthesis and manufacturing CMC development Commercial scale production

26. Key Partnership: Thesis Chemistry cGMP compliant Glass reactors: 2-L to 72-L Pressure vessels: 4-L & 20-L 20-L rotary evaporators Dedicated gowning area Dedicated chemical storage area HEPA filtered isolation room Tray and vacuum ovens Water filtration system

27. Our Experience Methods Developed in the Last 36 Months

28. Our Experience Recent Analytical Projects Humanized mAb for oncology therapy Method development & validation, release testing for CB, PK & TK bioanalytical studies, stability of CTM batches Small molecule for cardio-protection therapy Method development & validation, impurity characterization, TK & PK studies, Phase I & III bioanalytical studies Oligonucleotide drug product for blocking P-53 apoptosis in oncology treatment Method development & validation, stability of CTM batches Recombinant single fusion protein drug product (86 KDa) Complete peptide mapping by UPLC-UV and UPLC-MS-MS Clotrimazole analog for oncology treatment Formulation support, method development & validation, pre-clinical tox bio-analytical, stability of API & product

29. Our Experience Recent Analytical Projects Multiple antigens used in biomarker assay kits Method development & verification of multiple methods for QC of assay kits Transfer methods to kit & instrument manufacturer Anti-retroviral microbicide for HIV treatment Method development & validation, dissolution studies, stability testing Aerosol fentanyl pain relief product Method development & validation, In vitro release studies Aerosol bucchal insulin product Method development & validation, raw material compendial testing Toll-like receptor (TLR) blocker for autoimmune therapies Method development & validation, Phase I bioanalytical trial samples Multiple raw material characterization for large biotech Dozens of compendial tests for characterization and release

30. Our Experience Recent Bioanalytical Projects Determination of a vitamin B metabolite and two other primary vitamers in human plasma by UPLC/HPLC with post column derivatization and fluorescence Determination of an oncology compound in rat and dog serum by UPLC with UV Detection Determination of humanized mAb in monkey and human serum by ELISA Determination of caffeine in human plasma by LC/MS/MS Determination of ASA & SA in rat by UPLC/MS/MS

31. Our Experience Recent In Vitro Release Testing Projects Liposome encapsulated analgesic for pulmonary inhaled delivery Comparison study between Franz cell and Enhancer cell techniques for the calculation of drug release Anti-retroviral microbicide for HIV prevention (vaginal capsule suppository) IVRT study for a reliable QC method to discriminate release characteristics in lot to lot uniformity and discriminate formulation changes Anti-retroviral microbicide for HIV prevention (vaginal gel) IVRT study comparing Franz cell vs. Enhancer cell techniques for best IVRT methodology Developed and validated IVRT and HPLC assay methods Vaginal cream Developed and validated IVRT method for comparison study for site transfer Study for FDA approval and SUPAC related changes

32. Thank you!